Harris, K. E., Lorentsen, K. J., Malik-Chaudhry, H. K., Loughlin, K., Basappa, H. M., Hartstein, S., . . . Trinklein, N. D. (2021). A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells. Sci Rep.
Chicago Style aipamenaHarris, Katherine E., et al. "A Bispecific Antibody Agonist of the IL-2 Heterodimeric Receptor Preferentially Promotes in Vivo Expansion of CD8 and NK Cells." Sci Rep 2021.
MLA aipamenaHarris, Katherine E., et al. "A Bispecific Antibody Agonist of the IL-2 Heterodimeric Receptor Preferentially Promotes in Vivo Expansion of CD8 and NK Cells." Sci Rep 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.